炎症和内皮功能障碍的循环标记与基于人口的弗雷明汉姆心脏研究中的内 Carotid Intima-Media 厚度的增加进展有关
Hediyeh Baradaran1, Adlin Pinheiro2,3, Emelia J Benjamin3,4,5
1Department of Radiology and Imaging Sciences University of Utah Salt Lake City UT USA.
Journal of the American Heart Association
|November 17, 2025
概括
炎症和内皮功能障碍的标志物与动脉内心介质厚度 (CIMT) 进展的增加有关. 在弗雷明汉心脏研究队列中的这项研究强调了与亚临床动脉样硬化相关的关键炎症标志物.
科学领域:
- 心血管科学 心血管科学
- 生物标志物 生物标志物
- 动脉样硬化研究 动脉样硬化研究
背景情况:
- 亚临床动脉样硬化,以动脉内心介质厚度 (CIMT) 表示,与心血管和脑血管疾病有关.
- 循环炎症标志物和CIMT进展之间的关联仍然不清楚.
- 这项研究调查了弗雷明汉心脏研究 (FHS) 队列中炎症,内皮功能障碍标志物和CIMT进展之间的关系.
研究的目的:
- 确定炎症和内皮功能障碍的循环标志物是否与内动脉内心介质厚度 (ICIMT) 的进展有关.
- 检查这些标记物与ICIMT之间的横截面关联.
- 在分析中调整已确定的血管风险因素和基线ICIMT.
主要方法:
- 利用多变量线性回归分析了来自弗雷明汉心脏研究的2264名参与者的数据.
- 评估了特定循环炎症标志物与横截面ICIMT和ICIMT进展 (毫米/年变化率) 之间的关联.
- 主要分析根据年龄,性别,高血压,糖尿病,APOE4,BMI和吸烟情况进行了调整;次要分析也根据基线ICIMT进行了调整.
主要成果:
- 较高的基线水平的C-反应蛋白,脂蛋白相关的脂酶A活性,和异质与增加的ICIMT进展显著相关 (p<0.05).
- 横截面分析显示,高水平的互白素-6,骨质保护素和P-选择素与更高的ICIMT之间存在显著的关联.
- 这些发现被调整为关键血管风险因素和基线CIMT测量.
结论:
- 炎症和内皮功能障碍的特定循环标志物与增加的ICIMT显著相关.
- 这些炎症标志物与动脉动脉样硬化的进展有关.
- 这些结果有助于了解与心血管疾病发展有关的炎症途径.
相关概念视频
Inflammation
61.5K
Overview
61.5K
Atherosclerosis I: Introduction
853
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
853
Coronary Artery Disease I: Introduction
863
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
863
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
525
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
525
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
450
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
450
Peripheral Artery Disease I: Introduction
295
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
295


